Author Affiliations: Department of Clinical Science, University of Milan, Luigi Sacco Hospital, Milan, Italy (Drs Carugati and Franzetti); and Department of Clinical Medicine and Prevention, University of Milan Bicocca, and Respiratory Department, San Gerardo Hospital, Monza, Italy (Dr Aliberti).
We read with interest the study recently published by Carratalà and coworkers.1 The authors developed a 3-step critical pathway to reduce duration of intravenous antibiotic therapy and length of stay (LOS) of hospitalized patients with community-acquired pneumonia (CAP). The median duration of LOS was 3.9 days and 6.0 days in the interventional and usual care group, respectively. The authors found no significant differences between the 2 study groups in terms of 30-day mortality, and they concluded that this pathway is effective and safe to use. In his commentary, Sharpe2 called for a rapid implementation of this strategy. However, some remarks should be pointed out in this regard.
Carugati M, Aliberti S, Franzetti F. Should Health Care Systems and Health Care Providers Implement a New Pathway for Hospitalized Patients With Community-Acquired Pneumonia? Arch Intern Med. 2012;172(22):1771–1772. doi:10.1001/2013.jamainternmed.459
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: